Latest Post

Summary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group (Covis …

Summary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR Spinal …

Summary : Clover Biopharmaceuticals, Ltd. (Clover; Stock Code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates and Ascentage Pharma (6855.HK), a globally focused biopharmaceutical company …

Summary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials and regulatory submissions for its inactivated, adjuvanted COVID-19 …

Summary : -Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced that wholly owned subsidiary Mitsui Chemicals Agro, Inc. (Tokyo; President & CEO: OZAWA Satoshi) has completed …

Summary – -The Indian Institute of Science (IISc) department of Microbiology and Cell Biology (MCB) and the Centre for Infectious Disease Research (CIDR) researchers and their  collaborators from the Bangalore …

Synopsis -Ahead of its New Year’s Day decision deadline at the FDA, Xeris Biopharma has snagged an approval for Recorlev, a drug formerly known as levoketoconazole. Based on results from …

Synopsis : -Novo Holdings acquired South Carolina-based sterile injectables manufacturer Ritedose for an undisclosed price. Ritedose, which specializes in blow-fill-seal technology and has been focusing on the outsourced sterile compounding …

Summary : Sperogenix will receive exclusive rights for development and commercialization of vamorolone for the treatment of Duchenne muscular dystrophy (DMD) and any other rare disease Santhera to receive a double-digit upfront cash payment plus short-term US-regulatory milestones amounting to USD 20 million combined, in a deal valued …

Synopsis: -Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US Patent No. 9,187,405 covering a dosing regimen for …

Summary: ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid and a well-tolerated safety profile in …

Synopsis: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine, Covaxin to Afghanistan. Bharat Biotech on Monday informed …

Summary ; -Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric cancers, utilizing Allarity’s DRP® companion diagnostics -Allarity has submitted a new drug application …

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President & CEO Gerald Commissiong will be presenting at the upcoming Emerging …

Summary : Received the CES 2022 Innovation Awards in Health and Wellness following a CES 2018 Best of Innovation Award in VR/AR Looxid Labs Inc., a Virtual Reality(VR)-based proactive mental …

Synopsis; – The Drugs Technical Advisory Board (DTAB) has recommended introduction of barcode or QR code in the top 300 brands of drug products available in the Indian market to …

Summary : –  Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – Together with recent pseudo- and live virus results, additional …

Bioretec Ltd a globally operating Finnish medical device company, announced that the company has submitted an application for the CE mark for the first product in its new RemeOs product …

Blueprint Medicines Corporation  a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on December 1, 2021, the Compensation Committee of Blueprint …

Summary : – Expands Blueprint Medicines’ lung cancer pipeline with LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations – Investigational New Drug application for LNG-451 …

Summary : Granules India on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts indicated for the treatment of Attention Deficit Hyperactivity …

Summary : -Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi’s challenge over unpatentability of device patents for disposable insulin injection …

Summary : Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapies, today announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis’ investigational antisense …

Highlights: -Visiongain has published a new report on Antimicrobial Hospital Curtains Market Report to 2031. Market is segmented by type (Reusable antimicrobial hospital curtains, Disposable antimicrobial hospital curtains), BY Material …

Highlights: Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support global regulatory approvals No serious adverse events and safety …

Synopsis : Northshore Clinical Labs raised $25,000 in November alone after recently becoming a premier sponsor of ShowerUp in Chicago. The non-profit organization offers those experiencing homelessness an opportunity to …

Synopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from the Drugs Controller General of India (DCGI) to …

Summary : This loan facility is the Company’s first green loan facility. The term and revolving loans under this facility are priced at 85 basis points over LIBOR JD.com, Inc. …

 Synopsis: Torrent Pharma announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, New Jersey, USA) and Ridgeback’s molnupiravir under the brand name Molnutor in …

Summary : -The ministry of health and family welfare has decided to extend the date of implementation of the unique device identification (UDI) of medical devices, which was to come …

Summary : Merck, known as MSD outside the United States and Canada, and Eisai announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the combination of …

Summary : Visiongain has published a new report on Antiseptics and Disinfectants Market Report to 2031. Market is segmented by type (Alcohol and Aldehyde, Phenol and derivatives, Biguanides and Amides, …

Summary : Visiongain has published a new report on Antithrombin Market Report to 2031. Market is segmented by source (Human, Goat milk, others), By Application (Therapeutics, Research, Diagnostic, Others), By …

Summary : -Royal Philips, a global leader in health technology, announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle aan den Ijssel, The Netherlands). As the hospital’s …

Summary : Daiichi Sankyo Company, Limited announced that the first patient was dosed in the global DESTINY-Lung04 phase 3 trial evaluating the efficacy and safety of Enhertu (trastuzumab deruxtecan), a …

 Summary : – Medikabazaar, an online B2B platform for medical supplies, is looking to achieve a gross merchandise value (GMV) of around US$700 million by March 2022 from US$400 million …

Summary : Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies and retailers nationwide The COVID-19 At-Home Test uses …

Synopsis: -The FDA recommended Takeda run an additional clinical study to resolve its questions around Eohilia, an oral suspension formulation of the corticosteroid budesonide, in eosinophilic esophagitis. (Takeda) – The …

Synopsis: After a special meeting, the Japanese drug reviewers ruled that existing data didn’t support an approval and are therefore seeking additional clinical data. Biogen and Eisai are now working …

Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced that on June 28, 2019 the Compensation Committee …

 Summary : Minim, Inc.  the creator of intelligent networking products under the Motorola brand, announced that Sean Doherty will be transitioning from his role as Chief Financial Officer to pursue …

Summary : -New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in disease activity observed over two years across both …

  Synopsis : – Slalom Launch Center to help Japanese organizations accelerate cloud transformation and modernize their technology services Amazon Web Services (AWS) and global consulting firm, Slalom, today announced …

 Synopsis : Cabozantinib is used for the treatment of metastatic medullary thyroid cancer, advanced renal cell carcinoma and hepatocellular carcinoma, BDR Pharma said in a statement. Kidney cancers rank about …

Summary : The total outlay of the scheme as decided by the government is Rs.6,940 crore. The scheme will provide financial incentives for selected participants on incremental sales of 41 …

Summary – BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced it has entered into a Master Service Agreement …

Summary – Launch of VYRA™ CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s proprietary technology, this 3-in-1 test is developed to distinguish between SARS-CoV-2 and Influenza A or …

Summary – New IND Expands Liver Disease Pipeline for CRV431 IND Clearance Allows CRV431 to Move Directly into Phase 2 for Hepatocellular Carcinoma Treatment New IND Provides for Complementary Therapeutic …

Synopsis : Company announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase an aggregate of 6,750 shares of its common …

HIGHLIGHTS $50 million term sheet executed with Sprott Private Resource Streaming and Royalty Corp (“SRSR”) outlining a proposed financing package to fund mine restart in stages: $8 million Royalty Convertible …